These derivatives have promoted the mRNA and protein level of Nrf2 and they have activated the Nrf2/ARE pathway in a transgenic adenocarcinoma mouse prostate (TRAMP) model of prostate cancer. Here, NFE2L2 is linked to prostate cancer.